Report Cover

United States Generic Injectable Drugs Market Report & Forecast 2021-2027


United States Generic Injectable Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions)
United States Generic Injectable Drugs Market Segment Percentages, By Type, 2020 (%)
    Small Molecule
    Large Molecule

United States Generic Injectable Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions)
United States Generic Injectable Drugs Market Segment Percentages, By Application, 2020 (%)
    Oncology
    Anesthesia
    Anti-Infectives
    Parenteral Nutrition
    Cardiovascular Diseases

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Generic Injectable Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Generic Injectable Drugs revenues share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Hospira (Pfizer Inc.)
    Fresenius Kabi
    Sandoz (Novartis)
    Hikma Pharmaceuticals PLC
    Dr. Reddy's Laboratories Ltd
    Grifols
    Nichi-Iko Group (Sagent)
    Teva Pharmaceutical
    Auromedics
    Sanofi
    Gland Pharma
    Endo International PLC
1 Introduction to Research & Analysis Reports
    1.1 Generic Injectable Drugs Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Generic Injectable Drugs Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Generic Injectable Drugs Overall Market Size
    2.1 United States Generic Injectable Drugs Market Size: 2021 VS 2027
    2.2 United States Generic Injectable Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints

3 Company Landscape
    3.1 Top Generic Injectable Drugs Players in United States Market
    3.2 Top United States Generic Injectable Drugs Companies Ranked by Revenue
    3.3 United States Generic Injectable Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Generic Injectable Drugs Companies in United States Market, by Revenue in 2020
    3.5 Companies Generic Injectable Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Generic Injectable Drugs Players in United States Market
        3.6.1 List of Tier 1 Generic Injectable Drugs Companies in United States
        3.6.2 List of Tier 2 and Tier 3 Generic Injectable Drugs Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Generic Injectable Drugs Market Size Markets, 2021 & 2027
        4.1.2 Small Molecule
        4.1.3 Large Molecule
    4.2 By Type - United States Generic Injectable Drugs Revenue & Forecasts
        4.2.1 By Type - United States Generic Injectable Drugs Revenue, 2016-2021
        4.2.2 By Type - United States Generic Injectable Drugs Revenue, 2022-2027
        4.2.3 By Type - United States Generic Injectable Drugs Revenue Market Share, 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Generic Injectable Drugs Market Size, 2021 & 2027
        5.1.2 Oncology
        5.1.3 Anesthesia
        5.1.4 Anti-Infectives
        5.1.5 Parenteral Nutrition
        5.1.6 Cardiovascular Diseases
    5.2 By Application - United States Generic Injectable Drugs Revenue & Forecasts
        5.2.1 By Application - United States Generic Injectable Drugs Revenue, 2016-2021
        5.2.2 By Application - United States Generic Injectable Drugs Revenue, 2022-2027
        5.2.3 By Application - United States Generic Injectable Drugs Revenue Market Share, 2016-2027

6 Generic Injectable Drugs Companies Profiles
    6.1 Hospira (Pfizer Inc.)
        6.1.1 Hospira (Pfizer Inc.) Company Details
        6.1.2 Hospira (Pfizer Inc.) Business Overview
        6.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Introduction
        6.1.4 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.1.5 Hospira (Pfizer Inc.) Recent Developments
    6.2 Fresenius Kabi
        6.2.1 Fresenius Kabi Company Details
        6.2.2 Fresenius Kabi Business Overview
        6.2.3 Fresenius Kabi Generic Injectable Drugs Introduction
        6.2.4 Fresenius Kabi Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.2.5 Fresenius Kabi Recent Developments
    6.3 Sandoz (Novartis)
        6.3.1 Sandoz (Novartis) Company Details
        6.3.2 Sandoz (Novartis) Business Overview
        6.3.3 Sandoz (Novartis) Generic Injectable Drugs Introduction
        6.3.4 Sandoz (Novartis) Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.3.5 Sandoz (Novartis) Recent Developments
    6.4 Hikma Pharmaceuticals PLC
        6.4.1 Hikma Pharmaceuticals PLC Company Details
        6.4.2 Hikma Pharmaceuticals PLC Business Overview
        6.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Introduction
        6.4.4 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.4.5 Hikma Pharmaceuticals PLC Recent Developments
    6.5 Dr. Reddy's Laboratories Ltd
        6.5.1 Dr. Reddy's Laboratories Ltd Company Details
        6.5.2 Dr. Reddy's Laboratories Ltd Business Overview
        6.5.3 Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Introduction
        6.5.4 Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.5.5 Dr. Reddy's Laboratories Ltd Recent Developments
    6.6 Grifols
        6.6.1 Grifols Company Details
        6.6.2 Grifols Business Overview
        6.6.3 Grifols Generic Injectable Drugs Introduction
        6.6.4 Grifols Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.6.5 Grifols Recent Developments
    6.7 Nichi-Iko Group (Sagent)
        6.7.1 Nichi-Iko Group (Sagent) Company Details
        6.7.2 Nichi-Iko Group (Sagent) Business Overview
        6.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Introduction
        6.7.4 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.7.5 Nichi-Iko Group (Sagent) Recent Developments
    6.8 Teva Pharmaceutical
        6.8.1 Teva Pharmaceutical Company Details
        6.8.2 Teva Pharmaceutical Business Overview
        6.8.3 Teva Pharmaceutical Generic Injectable Drugs Introduction
        6.8.4 Teva Pharmaceutical Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.8.5 Teva Pharmaceutical Recent Developments
    6.9 Auromedics
        6.9.1 Auromedics Company Details
        6.9.2 Auromedics Business Overview
        6.9.3 Auromedics Generic Injectable Drugs Introduction
        6.9.4 Auromedics Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.9.5 Auromedics Recent Developments
    6.10 Sanofi
        6.10.1 Sanofi Company Details
        6.10.2 Sanofi Business Overview
        6.10.3 Sanofi Generic Injectable Drugs Introduction
        6.10.4 Sanofi Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.10.5 Sanofi Recent Developments
    6.11 Gland Pharma
        6.11.1 Gland Pharma Company Details
        6.11.2 Gland Pharma Business Overview
        6.11.3 Gland Pharma Generic Injectable Drugs Introduction
        6.11.4 Gland Pharma Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.11.5 Gland Pharma Recent Developments
    6.12 Endo International PLC
        6.12.1 Endo International PLC Company Details
        6.12.2 Endo International PLC Business Overview
        6.12.3 Endo International PLC Generic Injectable Drugs Introduction
        6.12.4 Endo International PLC Generic Injectable Drugs Revenue in United States Market (2016-2021)
        6.12.5 Endo International PLC Recent Developments

7 Conclusion
8 Appendix
    8.1 Note
    8.2 Examples of Clients
    8.3 Author Details
    8.4 Disclaimer

List of Tables Table 1. Generic Injectable Drugs Market Opportunities & Trends in United States Market Table 2. Generic Injectable Drugs Market Drivers in United States Market Table 3. Generic Injectable Drugs Market Restraints in United States Market Table 4. Key Players of Generic Injectable Drugs in United States Market Table 5. Top Generic Injectable Drugs Players in United States Market, Ranking by Revenue (2019) Table 6. United States Generic Injectable Drugs Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Generic Injectable Drugs Revenue Share by Companies, 2016-2021 Table 8. Companies Generic Injectable Drugs Product Type Table 9. List of Tier 1 Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type - United States Generic Injectable Drugs Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Generic Injectable Drugs Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Generic Injectable Drugs Revenue (US$, Mn), 2022-2027 Table 14. By Application - United States Generic Injectable Drugs Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Generic Injectable Drugs Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Generic Injectable Drugs Revenue (US$, Mn), 2022-2027 Table 17. Hospira (Pfizer Inc.) Company Details Table 18. Hospira (Pfizer Inc.) Business Overview Table 19. Hospira (Pfizer Inc.) Generic Injectable Drugs Product Table 20. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Hospira (Pfizer Inc.) Recent Developments Table 22. Fresenius Kabi Company Details Table 23. Fresenius Kabi Business Overview Table 24. Fresenius Kabi Generic Injectable Drugs Product Table 25. Fresenius Kabi Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Fresenius Kabi Recent Developments Table 27. Sandoz (Novartis) Company Details Table 28. Sandoz (Novartis) Business Overview Table 29. Sandoz (Novartis) Generic Injectable Drugs Product Table 30. Sandoz (Novartis) Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Sandoz (Novartis) Recent Developments Table 32. Hikma Pharmaceuticals PLC Company Details Table 33. Hikma Pharmaceuticals PLC Business Overview Table 34. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Table 35. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Hikma Pharmaceuticals PLC Recent Developments Table 37. Dr. Reddy's Laboratories Ltd Company Details Table 38. Dr. Reddy's Laboratories Ltd Business Overview Table 39. Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Product Table 40. Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Dr. Reddy's Laboratories Ltd Recent Developments Table 42. Grifols Company Details Table 43. Grifols Business Overview Table 44. Grifols Generic Injectable Drugs Product Table 45. Grifols Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Grifols Recent Developments Table 47. Nichi-Iko Group (Sagent) Company Details Table 48. Nichi-Iko Group (Sagent) Business Overview Table 49. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Table 50. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Nichi-Iko Group (Sagent) Recent Developments Table 52. Teva Pharmaceutical Company Details Table 53. Teva Pharmaceutical Business Overview Table 54. Teva Pharmaceutical Generic Injectable Drugs Product Table 55. Teva Pharmaceutical Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 56. Teva Pharmaceutical Recent Developments Table 57. Auromedics Company Details Table 58. Auromedics Business Overview Table 59. Auromedics Generic Injectable Drugs Product Table 60. Auromedics Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 61. Auromedics Recent Developments Table 62. Sanofi Company Details Table 63. Sanofi Business Overview Table 64. Sanofi Generic Injectable Drugs Product Table 65. Sanofi Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 66. Sanofi Recent Developments Table 67. Gland Pharma Company Details Table 68. Gland Pharma Business Overview Table 69. Gland Pharma Generic Injectable Drugs Product Table 70. Gland Pharma Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 71. Gland Pharma Recent Developments Table 72. Endo International PLC Company Details Table 73. Endo International PLC Business Overview Table 74. Endo International PLC Generic Injectable Drugs Product Table 75. Endo International PLC Generic Injectable Drugs Revenue in United States Market (2016-2021) & (US$ Million) Table 76. Endo International PLC Recent Developments List of Figures Figure 1. Generic Injectable Drugs Segment by Type Figure 2. Generic Injectable Drugs Segment by Application Figure 3. United States Generic Injectable Drugs Market Overview: 2020 Figure 4. United States Generic Injectable Drugs Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Generic Injectable Drugs Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Generic Injectable Drugs Revenue in 2020 Figure 7. By Type - United States Generic Injectable Drugs Revenue Market Share, 2016-2027 Figure 8. By Application - United States Generic Injectable Drugs Revenue Market Share, 2016-2027 Figure 9. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Fresenius Kabi Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Sandoz (Novartis) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Dr. Reddy's Laboratories Ltd Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Grifols Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Teva Pharmaceutical Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. Auromedics Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. Sanofi Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 19. Gland Pharma Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 20. Endo International PLC Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us